ArticleFrontiers in neurology2023

Neuroprotection after cardiac arrest with 2-iminobiotin: a single center phase IIa study on safety, tolerability, and pharmacokinetics.

M M Admiraal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.